Circulating microRNA Testing for the Early Diagnosis and Follow-up of Colorectal Cancer Patients
Early detection of colorectal cancer (CRC) is key for prevention and the ability to impact long-term survival of CRC patients. However, the compliance rate of recommended colonoscopy for the population aged from 50 to 75 years is only 50–75 % in the US. A highly sensitive and specific non-invasive test is needed to enhance CRC management. As for late-stage patients, a non-invasive prognostic biomarker is also critical for improving patient treatment protocols. The discovery that non-coding microRNAs (miRNAs) are stable in body fluids such as plasma, serum and exosomes presents the opportunity to develop novel strategies, taking advantage of circulating miRNAs as early diagnostic biomarkers of CRC. The goal of using circulating miRNA-based prognostic biomarkers for CRC patients has been pursued extensively. In this review, we will try to cover the major recent advancements at the frontier of this research area.
KeywordsChronic Lymphocytic Leukemia Reverse Transcription Polymerase Chain Reaction Advanced Adenoma Adenoma Patient miRNA Quantification
Acknowledgments and Disclosures
This study was supported by R01CA155019 (Jingfang Ju) and R33CA147966 (Jingfang Ju). The authors have no conflicts of interest that are directly relevant to the content of this article.
- 1.American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2013. p. 1–64.Google Scholar
- 8.Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. 2007;7:36. doi: 10.1186/1472-6750-7-36.PubMedCrossRefPubMedCentralGoogle Scholar
- 15.Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H, et al. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PloS ONE. 2013;8(9):e75184. doi: 10.1371/journal.pone.0075184.
- 17.Yang IP, Tsai HL, Huang CW, Huang MY, Hou MF, Juo SH, et al. The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse. PloS One. 2013;8(6):e66842. doi: 10.1371/journal.pone.0066842.PubMedCrossRefPubMedCentralGoogle Scholar
- 31.Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol. 2010;25(10):1674–80. doi: 10.1111/j.1440-1746.2010.06417.x.PubMedCrossRefGoogle Scholar